Protalix BioTherapeutics (PLX) Net Margin Growth (5y) (2015 - 2026)
Protalix BioTherapeutics (PLX) Net Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Protalix BioTherapeutics |
176.47 Mn |
165.67 Mn |
29.62 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
10,605.00 |
| Dec 31, 2025 |
-4,890.00 |
| Sep 30, 2025 |
5,574.00 |
| Jun 30, 2025 |
4,071.00 |
| Mar 31, 2025 |
-4,255.00 |
| Dec 31, 2024 |
5,852.00 |
| Sep 30, 2024 |
4,324.00 |
| Jun 30, 2024 |
4,690.00 |
| Mar 31, 2024 |
-5,119.00 |
| Dec 31, 2023 |
7,894.00 |
| Sep 30, 2023 |
81,950.00 |
| Jun 30, 2023 |
47,179.00 |
| Mar 31, 2023 |
12,924.00 |
| Dec 31, 2022 |
54,597.00 |
| Jun 30, 2021 |
-17,028.00 |
| Mar 31, 2021 |
-4,117.00 |
| Sep 30, 2020 |
-20,651.00 |
| Jun 30, 2020 |
-12,142.00 |
| Mar 31, 2020 |
-2,521.00 |
| Mar 31, 2019 |
3,885.00 |
